Physician profile
Charles Pierce
NPI 1659548279
$4,242.86
in general payments reported to CMS, 2019-2025
18 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 76% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $20.81 · 2021: $256 · 2022: $777 · 2023: $334 · 2024: $1,574 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,060.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $677.78 | 2022-2025 | Phasix Mesh, Arista, Arista Ah Flexitip |
| Revance Therapeutics, INC. | $564.81 | 2024-2025 | Daxxify |
| Abbvie INC. | $503.02 | 2023-2025 | |
| Becton, Dickinson and Company | $398.93 | 2022-2024 | Phasix Mesh, Channel Drain |
| Allergan, INC. | $332.62 | 2019-2022 | |
| Axogen | $313.51 | 2019-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Kerecis Limited | $256.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $237.72 | 2024 | |
| Merz North America, INC. | $165.25 | 2020-2023 | Xeomin |
| Sientra, INC. | $164.23 | 2021-2022 | |
| Tela Bio, INC. | $162.49 | 2024 | Ovitex 2s |
| Baudax Bio INC. | $124.77 | 2022 | |
| Hologic Sales and Service, LLC | $88.05 | 2025 | Coolseal Generator |
| Mentor Worldwide LLC | $79.28 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Innocoll Pharmaceuticals Limited | $59.21 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $49.13 | 2021 | |
| Motiva USA, LLC | $44.48 | 2025 | |
| Dilon Technologies, INC. | $21.13 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.